The Selective HDAC6 Inhibitor ACY-738 Impacts Memory and Disease Regulation in an Animal Model of Multiple Sclerosis
Multiple sclerosis (MS) is a complex disease characterized by autoimmune demyelination and progressive neurodegeneration. Pathogenetic mechanisms of the disease remain largely unknown. Changes in synaptic functions have been reported; however, the significance of such alterations in the disease cour...
Main Author: | Patrizia LoPresti |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-06-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2019.00519/full |
Similar Items
-
Silent Free Fall at Disease Onset: A Perspective on Therapeutics for Progressive Multiple Sclerosis
by: Patrizia LoPresti
Published: (2018-11-01) -
HDAC6 in Diseases of Cognition and of Neurons
by: Patrizia LoPresti
Published: (2020-12-01) -
Serum-Based Biomarkers in Neurodegeneration and Multiple Sclerosis
by: Patrizia LoPresti
Published: (2022-05-01) -
Complement C3 mediates early hippocampal neurodegeneration and memory impairment in experimental multiple sclerosis
by: Julien Bourel, et al.
Published: (2021-12-01) -
Sex differences in brain atrophy in multiple sclerosis
by: Rhonda R. Voskuhl, et al.
Published: (2020-08-01)